Diuretic Drug Treatment in Indian General Practice for Beginners
For most hypertensive patients in Indian general practice settings, thiazide-type diuretics should be used as initial therapy, either alone or in combination with other classes of antihypertensive drugs. 1
First-Line Diuretic Options for Hypertension
Thiazide and Thiazide-like Diuretics
Hydrochlorothiazide (HCTZ)
- Starting dose: 12.5-25 mg once daily
- Maximum dose: 50 mg daily
- Brand names in India: Hydrazide, Aquazide-H
Chlorthalidone
- Starting dose: 12.5-15 mg once daily
- Maximum dose: 25-50 mg daily
- Brand names in India: Chlorthalidone, Thalitone
- Note: More potent than HCTZ at equivalent doses, with longer half-life (40-60 hours) 2
Indapamide
- Starting dose: 1.25-2.5 mg once daily
- Maximum dose: 5 mg daily
- Brand names in India: Indap, Natrilix
Loop Diuretics (for specific indications)
Furosemide
- Starting dose: 20-40 mg once or twice daily
- Maximum dose: 600 mg/day 3
- Brand names in India: Lasix, Frusemide, Frusid
Torsemide
- Starting dose: 5-10 mg once daily
- Maximum dose: 200 mg/day
- Brand names in India: Dytor, Tide
Potassium-Sparing Diuretics
Spironolactone
- Starting dose: 25 mg once daily
- Maximum dose: 100 mg daily for hypertension, up to 400 mg for hyperaldosteronism 4
- Brand names in India: Aldactone, Spirolac
Amiloride
- Starting dose: 5 mg once daily
- Maximum dose: 20 mg daily
- Usually combined with thiazides
Treatment Algorithm for Hypertension
Initial Assessment:
First-Line Therapy:
- Non-black patients: Start with low-dose thiazide diuretic (HCTZ 12.5-25 mg or chlorthalidone 12.5-15 mg)
- Black patients: Consider thiazide diuretic + calcium channel blocker 1
Monitoring and Dose Adjustment:
- Check electrolytes, renal function after 1-2 weeks of starting therapy
- If BP goal not achieved after 3-4 weeks, increase dose or add second agent
Combination Therapy:
Diuretic Treatment for Heart Failure
Initial Therapy:
- Loop diuretics (furosemide 20-40 mg daily) for symptomatic relief
- Always administer in addition to an ACE inhibitor 1
Dose Titration:
- If insufficient response, increase dose of diuretic
- Consider combination of loop diuretic and thiazide for resistant cases 1
Potassium-Sparing Diuretics:
- Add spironolactone 25 mg daily for advanced heart failure (NYHA III-IV) 1
- Monitor potassium levels closely when combining with ACE inhibitors
Diuretic Treatment for Ascites in Cirrhosis
Initial Therapy:
- Spironolactone monotherapy (starting dose 100 mg, increased to 400 mg) for first presentation of moderate ascites 1
Combination Therapy:
- For recurrent severe ascites or faster diuresis: spironolactone (100-400 mg) plus furosemide (40-160 mg) 1
Monitoring:
- Monitor for adverse events including electrolyte imbalances, renal dysfunction
- Almost half of patients require dose adjustment or discontinuation due to adverse events 1
Important Clinical Pearls
Dosing Considerations:
Monitoring Parameters:
- Serum electrolytes (particularly potassium, sodium)
- Renal function (BUN, creatinine)
- Blood pressure response
- Body weight (daily weighing for heart failure patients)
Common Pitfalls to Avoid:
- Underutilization of diuretics despite strong evidence for efficacy 5
- Excessive concern about metabolic side effects, which are minimal with low doses 6
- Inadequate sodium restriction (should limit to 5-6.5 g/day or 87-113 mmol sodium) 1
- Failure to recognize diuretic resistance (requiring combination therapy)
Special Considerations for Indian Practice:
- Cost-effectiveness: Generic thiazide diuretics are among the most affordable antihypertensives
- Consider heat and humidity factors that may affect fluid balance
- Dietary patterns in India often include high sodium content; emphasize dietary counseling
Patient Education Points
- Explain importance of daily weight monitoring for patients with heart failure or ascites
- Advise on sodium restriction in diet
- Counsel on potential side effects (dizziness, frequent urination, electrolyte disturbances)
- Emphasize importance of regular follow-up for monitoring
Thiazide diuretics remain underutilized despite strong evidence supporting their use as first-line agents for hypertension 5. When used appropriately, they are effective, well-tolerated, and can reduce cardiovascular morbidity and mortality 7.